Table 2 Treatment related characteristics of study participants at Jimma university medical center

Types of regimens

 DEXA + VCR + 6-MP + MTX + MTX(IT)

12

16.44

 VAD

8

10.96

 VCR + DOXO + PDN + L-ASP + MTX(IT)

5

6.85

 ABVE-PC

5

6.85

 EC

5

6.85

 ABVE

4

5.48

 VCD

4

5.48

 CISP + DOXO

3

4.10

 VCR + DOXO + L-ASP + MTX(IT)

2

2.74

 VCR + PDN + L-ASP + MTX(IT)

2

2.74

 VCR + CARBO + ETOPO

2

2.74

 VCR + CYCLO + PDN

2

2.74

 Ara-C + TIT

2

2.74

 VCR + CYCLO + Ara-C + 6-MP + L-ASP + MTX(IT)

2

2.74

 VCR + CYCLO + MTX + TIT

2

2.74

 VAC

2

2.74

 VCR + 6-MP + MTX(IT)

2

2.74

 Other

9

12.33

Number of chemotherapy drugs

 1—2 drugs

11

15.00

 3 – 5 drugs

52

71.30

  ≥ 6 drugs

10

13.70

Number of chemotherapy cycles

 1 cycle

17

23.30

 2 cycles

16

21.90

 3 cycles

20

27.40

 4 cycles

12

16.40

 5 cycles

6

8.30

 6 cycles

2

2.70